North America will dominate the global sacral nerve stimulator market, owing to high prevalence of chronic pain, epilepsy and Parkinson's disease in the region. The other factors driving growth in this regional are ageing population and rising prevalence of chronic disorders such as Alzheimer's disease. The Asia Pacific market is also growing at a fast pace due to increasing awareness about medications for chronic issues such as Parkinson's disease and epilepsy.
Rechargeable spinacord stimulator segment dominated the global sacral nerve stimulator market in 2018 with over 50% share followed by no chargeable spinacord stimulators. Europe is expected to have fastest growth rate during forecast period due to increasing demand for these devices for treatment of conditions such as neuropathic pain, Parkinson’s disease and epilepsy among others. In addition, ageing population coupled with rising prevalence rates of chronic conditions such as Alzheimer’s will drive considerable demand for these devices in this region.
In order to understand the market dynamics and future growth prospects of the sacral nerve stimulator market, insights from key industry experts are needed. The 3 key players in this market are Medtronic plc, Boston Scientific Corporation, and Nevro Corporation.
Boston Scientific Corporation is a leading medical device company that develops innovative therapeutic solutions that make it easier for people to live their best lives. The company's products focus on interventional cardiology, neuromodulation, vascular accessologies and general surgery.
Medtronic plc is a global medical technology company with headquarters in Ireland and operational headquarters in Minnesota, USA. The Company delivers innovative medical technologies to address unmet patient needs worldwide with six major therapy areas: cardiac rhythm management (CRM), diabetes care (including insulin pumps), spinal surgery - image guided procedures such as spine fusion; urology - prostate imaging systems; endocrinology-diabetes care treatments for type 2 diabetes; neurology-deep brain stimulation for Parkinson's disease; neurovascular intervention-carotid stenting and closure devices among others. Medtronic plc serves physicians who may be specialists or generalists who provide treatment across the continuum of healthcare services including acute hospitals through long term chronic care facilities or homecare settings.
The global sacral nerve stimulator market is highly competitive. The companies in the market are either established as a standalone player or have their roots in other related markets such as neurology, orthopedics, and urology.
Industry Growth Insights published a new data on “Sacral Nerve Stimulators Market”. The research report is titled “Sacral Nerve Stimulators Market research by Types (Rechargeable spinal-cord stimulator, Non-chargeable spinal-cord stimulator), By Applications (Parkinson's disease, Epilepsy, Pain, Other), By Players/Companies Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sacral Nerve Stimulators Market Research Report
By Type
Rechargeable spinal-cord stimulator, Non-chargeable spinal-cord stimulator
By Application
Parkinson's disease, Epilepsy, Pain, Other
By Companies
Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Sacral Nerve Stimulators Market Report Segments:
The global Sacral Nerve Stimulators market is segmented on the basis of:
Types
Rechargeable spinal-cord stimulator, Non-chargeable spinal-cord stimulator
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Parkinson's disease, Epilepsy, Pain, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- St. Jude Medical
- Cyberonics
- NeuroPace
- Synapse Biomedical
Highlights of The Sacral Nerve Stimulators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rechargeable spinal-cord stimulator
- Non-chargeable spinal-cord stimulator
- By Application:
- Parkinson's disease
- Epilepsy
- Pain
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sacral Nerve Stimulators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sacral nerve stimulators are medical devices that are used to treat conditions such as chronic pain, urinary incontinence, and sexual dysfunction. They work by sending electrical impulses through the sacral nerve (a spinal cord nerve) to the brain.
Some of the major players in the sacral nerve stimulators market are Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sacral Nerve Stimulators Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sacral Nerve Stimulators Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sacral Nerve Stimulators Market - Supply Chain
4.5. Global Sacral Nerve Stimulators Market Forecast
4.5.1. Sacral Nerve Stimulators Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sacral Nerve Stimulators Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sacral Nerve Stimulators Market Absolute $ Opportunity
5. Global Sacral Nerve Stimulators Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sacral Nerve Stimulators Market Size and Volume Forecast by Type
5.3.1. Rechargeable spinal-cord stimulator
5.3.2. Non-chargeable spinal-cord stimulator
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sacral Nerve Stimulators Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sacral Nerve Stimulators Market Size and Volume Forecast by Application
6.3.1. Parkinson's disease
6.3.2. Epilepsy
6.3.3. Pain
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sacral Nerve Stimulators Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sacral Nerve Stimulators Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sacral Nerve Stimulators Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sacral Nerve Stimulators Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sacral Nerve Stimulators Demand Share Forecast, 2019-2026
9. North America Sacral Nerve Stimulators Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sacral Nerve Stimulators Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sacral Nerve Stimulators Market Size and Volume Forecast by Application
9.4.1. Parkinson's disease
9.4.2. Epilepsy
9.4.3. Pain
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sacral Nerve Stimulators Market Size and Volume Forecast by Type
9.7.1. Rechargeable spinal-cord stimulator
9.7.2. Non-chargeable spinal-cord stimulator
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sacral Nerve Stimulators Demand Share Forecast, 2019-2026
10. Latin America Sacral Nerve Stimulators Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sacral Nerve Stimulators Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sacral Nerve Stimulators Market Size and Volume Forecast by Application
10.4.1. Parkinson's disease
10.4.2. Epilepsy
10.4.3. Pain
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sacral Nerve Stimulators Market Size and Volume Forecast by Type
10.7.1. Rechargeable spinal-cord stimulator
10.7.2. Non-chargeable spinal-cord stimulator
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sacral Nerve Stimulators Demand Share Forecast, 2019-2026
11. Europe Sacral Nerve Stimulators Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sacral Nerve Stimulators Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sacral Nerve Stimulators Market Size and Volume Forecast by Application
11.4.1. Parkinson's disease
11.4.2. Epilepsy
11.4.3. Pain
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sacral Nerve Stimulators Market Size and Volume Forecast by Type
11.7.1. Rechargeable spinal-cord stimulator
11.7.2. Non-chargeable spinal-cord stimulator
11.8.Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sacral Nerve Stimulators Demand Share, 2019-2026
12. Asia Pacific Sacral Nerve Stimulators Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sacral Nerve Stimulators Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sacral Nerve Stimulators Market Size and Volume Forecast by Application
12.4.1. Parkinson's disease
12.4.2. Epilepsy
12.4.3. Pain
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sacral Nerve Stimulators Market Size and Volume Forecast by Type
12.7.1. Rechargeable spinal-cord stimulator
12.7.2. Non-chargeable spinal-cord stimulator
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sacral Nerve Stimulators Demand Share, 2019-2026
13. Middle East & Africa Sacral Nerve Stimulators Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sacral Nerve Stimulators Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sacral Nerve Stimulators Market Size and Volume Forecast by Application
13.4.1. Parkinson's disease
13.4.2. Epilepsy
13.4.3. Pain
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sacral Nerve Stimulators Market Size and Volume Forecast by Type
13.7.1. Rechargeable spinal-cord stimulator
13.7.2. Non-chargeable spinal-cord stimulator
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sacral Nerve Stimulators Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sacral Nerve Stimulators Market: Market Share Analysis
14.2. Sacral Nerve Stimulators Distributors and Customers
14.3. Sacral Nerve Stimulators Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St. Jude Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cyberonics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. NeuroPace
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Synapse Biomedical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
